{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:13:46Z","timestamp":1793042026671,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess the global burden and health inequalities of laryngeal cancer from 1990 to 2021 and to project future trends up to 2040.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the 2021 Global Burden of Disease (GBD) data, this study analyzed trends in prevalence (ASPR), incidence (ASIR), mortality (ASDR), and disability-adjusted life years (DALYs) of laryngeal cancer from 2009 to 2021, with annual percentage change (EAPC) estimates. Inequalities were assessed using the Slope Index of Inequality (SII) and Concentration Index (CI), while future projections to 2040 were made using the Bayesian Age-Period-Cohort (BAPC) model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, there were approximately 1.1 million global laryngeal cancer cases (an age-standardized prevalence rate (ASPR) of 12.56 per 100,000, 95% UI: 11.76\u201313.49). The age-standardized incidence rate (ASIR), the age-standardized mortality rate (ASDR), and disability-adjusted life years (DALYs) rates were 2.29, 1.35, and 35.8 per 100,000, respectively. Significant disparities were observed across regions and SDI levels: high SDI regions had the highest incidence rates, while middle-low SDI regions experienced the greatest mortality and DALY burden. Central Europe had the highest ASPR, ASIR, and DALY rates, while the Caribbean reported the highest ASDR. From 1990 to 2021, the DALYs Slope Index of Inequality (SII) dropped from 37.75 (95% CI: 26.92\u201348.58) to -11.57 (95% CI: -22.14 to -1.00), indicating improved equity in health outcomes between high- and low-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the global burden of laryngeal cancer is projected to decline by 2040, significant health disparities persist. Addressing these inequalities will require sustained efforts, including equitable resource allocation, improved access to healthcare, and targeted public health interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1617613","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:31:34Z","timestamp":1752816694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Global, regional, and national larynx cancer burden and health inequality analysis from 1990 to 2021 with a prediction from 2022 to 2040"],"prefix":"10.3389","volume":"15","author":[{"given":"Junjie","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"151787","DOI":"10.1016\/j.anndiagpath.2021.151787","article-title":"Biomarkers of laryngeal squamous cell carcinoma: a review","volume":"54","author":"Cavaliere","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.12865\/CHSJ.43.04.14","article-title":"Clinical, histological and immunohistochemical evaluation of larynx cancer","volume":"43","author":"Ciolofan","year":"2017","journal-title":"Curr Health Sci J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.18632\/aging.102762","article-title":"Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study","volume":"12","author":"Deng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1186\/s12889-022-14654-z","article-title":"Global trend and risk factors of the disease burden for pharynx and larynx cancers between 1990 and 2019: a systematic analysis of the global burden of disease study 2019","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Public Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12913","DOI":"10.3390\/ijms241612913","article-title":"Updates on larynx cancer: risk factors and oncogenesis","volume":"24","author":"Liberale","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21147\/j.issn.1000-9604.2020.01.03","article-title":"Updates on larynx cancer epidemiology","volume":"32","author":"Nocini","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2016.3669","article-title":"Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer","volume":"143","author":"Wolf","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the global burden of disease study 2021","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol"},{"key":"B14","volume-title":"Handbook on health inequality monitoring: with a","year":"2013"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.v28:29","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v10.5","article-title":"Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-022-09923-4","article-title":"Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.07.003","article-title":"Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: Implications from the Global Burden of Disease Study 2019","volume":"59","author":"Wu","year":"2024","journal-title":"J Adv Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050387","article-title":"Temporal trends in incidence and mortality rates of laryngeal cancer at the global, regional and national levels, 1990\u20132017","volume":"11","author":"Wang","year":"2021","journal-title":"BMJ Open"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v147.11","article-title":"Profiling global cancer incidence and mortality by socioeconomic development","volume":"147","author":"Lortet-Tieulent","year":"2020","journal-title":"Int J Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.3390\/ijerph20064737","article-title":"Management of locally advanced laryngeal cancer\u2014From risk factors to treatment, the experience of a tertiary hospital from eastern europe","volume":"20","author":"C\u00eerstea","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2500693","DOI":"10.1080\/07853890.2025.2500693","article-title":"Tobacco and alcohol use are the risk factors responsible for the greatest burden of head and neck cancers: a study from the Global Burden of Disease Study 2019","volume":"57","author":"Yuan","year":"2025","journal-title":"Ann Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwk066","article-title":"Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe","volume":"165","author":"Hashibe","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000902","article-title":"Updated disease distributions, risk factors, and trends of laryngeal cancer: a global analysis of cancer registries","volume":"110","author":"Huang","year":"2024","journal-title":"Int J Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13690-024-01333-1","article-title":"Laryngeal cancer incidence trends in the United States over 2000\u20132020: a population-based analysis","volume":"82","author":"Mousavi","year":"2024","journal-title":"Arch Public Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph8040976","article-title":"Intensity and inhalation of smoking in the aetiology of laryngeal cancer","volume":"8","author":"Ramroth","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.3390\/nu13093173","article-title":"Alcohol and cancer: epidemiology and biological mechanisms","volume":"13","author":"Rumgay","year":"2021","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/alcalc\/agu082","article-title":"Alcohol consumption among the over 50s:\u00a0international comparisons","volume":"50","author":"Gell","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60264-1","article-title":"Global trends and projections for tobacco use, 1990\u20132025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control","volume":"385","author":"Bilano","year":"2015","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk179","article-title":"Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and\u00a0the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium","volume":"99","author":"Hashibe","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-030-30766-4_10","article-title":"Occupational risk factors of laryngeal cancer","author":"Boffetta","year":"2020","journal-title":"Occupational cancers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/cam4.2017.6.issue-8","article-title":"Hormone factors play a favorable role in female head and neck cancer risk","volume":"6","author":"Hashim","year":"2017","journal-title":"Cancer Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/00016489.2017.1373851","article-title":"Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-\u03b1 and prolactin receptor expression and influence of prognosis","volume":"138","author":"Fei","year":"2018","journal-title":"Acta Otolaryngol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12672-013-0161-y","article-title":"17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36","volume":"5","author":"Schwartz","year":"2014","journal-title":"Horm Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108498","DOI":"10.1016\/j.steroids.2019.108498","article-title":"Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer","volume":"152","author":"Verma","year":"2019","journal-title":"Steroids"},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.steroids.2017.11.012","article-title":"Estradiol\u00a0receptor profile and estrogen responsiveness in laryngeal cancer\u00a0and\u00a0clinical outcomes","volume":"142","author":"Schwartz","year":"2019","journal-title":"Steroids"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1617613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T10:22:22Z","timestamp":1753957342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1617613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":37,"alternative-id":["10.3389\/fonc.2025.1617613"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1617613","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"1617613"}}